Abstract
Breast cancer is frequently a hormone-dependent tumour, and several studies have suggested that the pineal gland hormone melatonin may influence the growth and development of this malignancy. Subcutaneous injections of melatonin have been shown to inhibit, and pinealectomy to enhance, the development of dimethyl benz(a)anthracene (DMBA)-induced mammary tumours in rats1. Use of the psychotropic drug thorazine, which increases plasma melatonin levels2, has been associated with a decreased incidence of breast cancer in psychiatric patients3. Calcification of the pineal gland has been correlated with an increased incidence of breast cancer in women4. While the mechanism by which melatonin influences these tumours is unknown, both human breast cancer and DMBA-induced tumours contain oestrogen receptors (ER) and respond to changes in the oestrogen milieu5–7. We therefore wondered whether melatonin might be altering ER binding activity of these tumours. We report here that in vitro incubation of MCF-7 human breast cancer cells with melatonin in physiological conditions increased the cytoplasmic and nuclear ER activity of these cells within 40 min, giving no change in the equilibrium dissociation constant (Kd) of the receptor. This induction was blocked by cycloheximide, and thus requires continuous protein synthesis. The modulation of ER binding activity of breast cancer by another endogenous hormone may be important for understanding the behaviour and treatment of this disease, and may provide insight into the factors regulating the synthesis and metabolism of steroid hormone receptors.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Tamarkin, L. et al. Cancer Res. 41, 4432–4436 (1981).
Wurtman, R. J. & Axelrod, J. Nature 212, 12–313 (1966).
Brugmans, J., Verbryggen, F., Dom, J. & Schuermans, V. Lancet i, 502–503 (1973).
Cohen, M., Lippman, M. E. & Chabner, B. Lancet i, 814–815 (1978).
Desombre, E. R., Greene, G. L. & Jensen, E. V. in Hormones, Receptors and Breast Cancer (ed. McGuire, W. L.) 1–14 (Raven, New York, 1978).
Asselin, J., Melancon, R., Moachin, G. & Belanger, A. Cancer Res. 40, 1612–1622 (1980).
Huggins, C., Briziarelli, G. & Sutton, H. Jr J. exp. Med. 109, 25–42 (1959).
Arendt, J., Wetterberg, L., Heyden, T., Sizonenko, P. C. & Paunier, L. Hormone Res. 8, 65–75 (1977).
Scatchard, G. Ann. N.Y. Acad. Sci. 51, 660–666 (1949).
Aitken, S. & Lippman, M. E. J. Steroid Biochem. 8, 77–80 (1977).
Danforth, D. N. Jr, Tamarkin, L., Do, R. & Lippman, M. E. Endocrinology 113, 81–85 (1983).
Gibbs, F. P. & Vriend, J. Endocrinology 109, 1796–1798 (1981).
Horwitz, K. B. & McGuire, W. L. J. biol. Chem. 255, 9699–9705 (1980).
Eckert, R. L., Rorke, E. A. & Katzenellenbogen, W. L. Endocrine Soc. 64th a. Meet. Abstr. 29 (1982).
Zava, D. & McGuire, W. L. J. biol. Chem. 352, 3703–3708 (1977).
Edwards, D. P., Martin, P. M., Horwitz, K. B., Chamness, G. C. & McGuire, W. L. Expl. Cell Res. 127, 197–213 (1980).
Henderson, C. & Canellos, G. P. New Engl. J. Med. 302, 78–90 (1980).
Horwitz, K. B., Aiginger, P., Kutten, F. & McGuire, W. L. Endocrinology 108, 1703–1709 (1981).
Neifeld, J., Lippman, M. E. & Tormey, D. J. biol. Chem. 252, 2972–2977 (1977).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Danforth, D., Tamarkin, L. & Lippman, M. Melatonin increases oestrogen receptor binding activity of human breast cancer cells. Nature 305, 323–325 (1983). https://doi.org/10.1038/305323a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/305323a0
This article is cited by
-
Preventive and curative effect of melatonin on mammary carcinogenesis induced by dimethylbenz[a]anthracene in the female Sprague–Dawley rat
Breast Cancer Research (2005)
-
Tissue-specific modulation of rat glucocorticoid receptor binding activity by melatonin
Experientia (1993)
-
Is melatonin really an in vitro inhibitor of human breast cancer cell proliferation?
In Vitro Cellular & Developmental Biology - Animal (1992)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.